1
Clinical Trial to Evaluate the Efficacy of Metadoxine as a Therapy for Patients With Non-alcoholic Steatohepatitis
Condition(s):Non-alcoholic SteatohepatitisLast Updated:August 27, 2021Suspended
Metadoxine as an Intervention: 13 Clinical Trials, Page 1 of 2
Hide Studies Not Open or Pending
2
Efficacy Study of Metadoxine SR Formulation in Attention Deficit Hyperactivity Disorder (ADHD) Subjects
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:March 13, 2017Completed
3
Effect of Metadoxine on Oxidative Stress in Non-alcoholic Hepatic Steatosis
Condition(s):NAFLD; Pre-diabetesLast Updated:January 31, 2019Unknown status
4
Clinical Efficacy & Safety, of Metadoxine (MG01CI) Extended Release in Attention-Deficit Hyperactivity Disorder (ADHD)
Condition(s):ADHDLast Updated:April 20, 2012Completed
5
A Phase 1 Study to Assess Pharmacokinetics of Metadoxine (MG01CI) 1400 mg, Administered to Healthy Volunteers
Condition(s):Healthy Adult SubjectsLast Updated:January 14, 2014Completed
6
Study Comparing Two Doses of MG01CI and Placebo in Adults With Predominantly Inattentive Attention Deficit Hyperactivity Disorder
Condition(s):ADHD Predominantly Inattentive TypeLast Updated:January 14, 2014Completed
7
Metadoxine as a Therapy for Severe Alcoholic Hepatitis
Condition(s):Severe Alcoholic HepatitisLast Updated:November 11, 2014Completed
8
Safety and Tolerability Study of Metadoxine Extended Release (MDX) (Previously Known as MG01CI) in PI-ADHD Adolescent Subjects
Condition(s):ADHD, Predominantly Inattentive TypeLast Updated:March 4, 2015Completed
9
A 6-week, Study of MG01CI Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X Syndrome
Condition(s):Fragile X SyndromeLast Updated:July 6, 2016Completed
10
A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease
Condition(s):Alcoholism,; Alcoholic Liver DiseaseLast Updated:July 22, 2015Completed